Pharmacists in Spartanburg, South Carolina


157 Pharmacists found in Spartanburg
male pharmacist

Thadd Hirschy, PHARM.D.


Pharmacist
1233 Boiling Springs Rd, Spartanburg, SC 29303
800-494-7127    

female pharmacist

Mrs. Theresa Worden Bengston, RPH


Pharmacist
2401 Reidville Rd, Spartanburg, SC 29301
864-576-0401     864-576-1823

male pharmacist

Thomas Allen Keith Jr., R.PH


Pharmacist
1908 East Main Street, Spartanburg, SC 29307
864-253-1830     864-253-1828



female pharmacist

Toni R Neal, R.PH


Pharmacist
4010 Anderson Mill Rd, Spartanburg, SC 29301
864-809-8596    

female pharmacist

Dr. Vanessa Ermani, PHARMD


Pharmacist
2151 E Main St, Spartanburg, SC 29307
864-529-0379    

female pharmacist

Vasilia Pardalakis


Pharmacist
1751 E Main St, Spartanburg, SC 29307
864-573-5313    

female pharmacist

Vela Barner, PHARMD


Pharmacist
87 Garner Rd, Spartanburg, SC 29303
864-582-6740    

female pharmacist

Mrs. Vicki Hawkins


Pharmacist
87 Garner Rd, Spartanburg, SC 29303
864-583-5428     864-597-1498

male pharmacist

Viren C Patel, RPH


Pharmacist
1510 W O Ezell Blvd, Spartanburg, SC 29301
864-574-0038    

female pharmacist

Mrs. Virginia Parker Ceva, RPH


Pharmacist
2195 Southport Rd, Spartanburg, SC 29306
864-585-2576    

male pharmacist

William Hildebrandt, R.PH.


Pharmacist
1700 Skylyn Dr, Spartanburg, SC 29307
864-573-3792    

female pharmacist

Dr. Yin Lam Wong, PHARMD


Pharmacist
101 E Wood St, Spartanburg, SC 29303
864-560-6779     864-560-7316

female pharmacist

Yuliya Neagu, PHARMD


Pharmacist
87 Garner Rd, Spartanburg, SC 29303
864-598-9830    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.